PRESS RELEASE published on 04/24/2025 at 14:00, 1 year 1 month ago Eckert & Ziegler Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Pentixapharm Eckert & Ziegler SE signs manufacturing agreement with Pentixapharm for Y90-PentixaTher, a targeted radiolabeled peptide therapeutic for cancer treatment Manufacturing Agreement Eckert & Ziegler SE Radiopharmaceuticals Pentixapharm Y90-PentixaTher
BRIEF published on 04/11/2025 at 10:35, 1 year 1 month ago Eckert & Ziegler Proposes €0.50 Dividend for FY 2024 Annual General Meeting Dividend Eckert & Ziegler Financial Year 2024 TecDax
PRESS RELEASE published on 04/11/2025 at 10:30, 1 year 1 month ago Eckert & Ziegler Proposes Dividend of € 0.50 for FY 2024 Eckert & Ziegler SE proposes dividend of €0.50 per share for FY 2024. The Annual General Meeting to be held on June 18, 2025 in Berlin Annual General Meeting Shareholders Dividend Eckert & Ziegler SE FY 2024
BRIEF published on 04/10/2025 at 15:05, 1 year 1 month ago Eckert & Ziegler: US Consul Visits Braunschweig Radiopharmaceutical Facility Cancer Treatment Radiopharmaceuticals Lutetium-177 US Consul Visit Expansion Investment
PRESS RELEASE published on 04/10/2025 at 15:00, 1 year 1 month ago Eckert & Ziegler: US Consul Visits Radiopharmaceutical Production in Braunschweig US Consul General Jason Chue visits Eckert & Ziegler's radiopharmaceutical production site in Braunschweig, witnessing the production of cancer diagnostics and therapy solutions Eckert & Ziegler Cancer Therapy Radiopharmaceuticals Lutetium-177 Transatlantic Cooperation
BRIEF published on 03/27/2025 at 07:50, 1 year 2 months ago Eckert & Ziegler Reports Record Year in 2024 Eckert & Ziegler 2024 Financial Results Medical Segment Isotope Products 2025 Forecast
PRESS RELEASE published on 03/27/2025 at 07:45, 1 year 2 months ago Eckert & Ziegler: Record year 2024 with new all-time highs Eckert & Ziegler SE achieved record sales of €295.8 million in 2024, with significant growth in Medical and Isotope Products segments. Forecasting sales of €320 million and EBIT of €78 million for 2025 Record Sales Eckert & Ziegler SE 2024 Financial Year Medical Segment Isotope Products Segment
BRIEF published on 03/25/2025 at 09:35, 1 year 2 months ago Eckert & Ziegler to Provide Actinium Pharmaceuticals with Actinium-225 Clinical Trials Acute Myeloid Leukemia Actinium-225 Supply Targeted Radiotherapy Global Shortage
PRESS RELEASE published on 03/25/2025 at 09:30, 1 year 2 months ago Eckert & Ziegler to Supply Actinium Pharmaceuticals with Ac-225 for Comprehensive Development Activities Eckert & Ziegler SE to supply Actinium Pharmaceuticals with Ac-225 for comprehensive development activities, targeting cancer treatment with radiotherapies Cancer Treatment Eckert & Ziegler SE Radiotherapy Ac-225 Actinium Pharmaceuticals
BRIEF published on 03/20/2025 at 14:05, 1 year 2 months ago Eckert & Ziegler Partner with AtomVie on Lutetium-177 Supply Radiopharmaceuticals Lutetium-177 Theralugand Global Agreement AtomVie Partnership
Published on 05/27/2026 at 15:25, 1 hour 46 minutes ago LaFleur Announces Upsize of Bought Deal Equity Offerings for Gross Proceeds of C$10 Million
Published on 05/27/2026 at 15:22, 1 hour 49 minutes ago AmeriTrust Announces First Quarter 2026 Financial Results
Published on 05/27/2026 at 15:15, 1 hour 56 minutes ago Storm Exploration Begins Field Program on VMS Target at Gold Standard
Published on 05/27/2026 at 15:00, 2 hours 11 minutes ago Jaguar Health Compliant with Nasdaq Bid Price Rule
Published on 05/27/2026 at 14:49, 2 hours 22 minutes ago Sekur Private Data Signs Defense Distribution Agreement with Elyon International, Marking Strategic Shift to Defense, Government and Enterprise Communications
Published on 05/27/2026 at 17:02, 8 minutes ago EQS-Adhoc: HMS Bergbau AG: HMS Bergbau publishes forecast for 2026 – significant growth expected in revenue and operating profit
Published on 05/27/2026 at 16:45, 25 minutes ago Onlineprinters posts strong increase in revenues and profitability in the first quarter of 2026
Published on 05/27/2026 at 16:37, 33 minutes ago EQS-Adhoc: Verbio SE: Verbio increases EBITDA forecast for the financial year 2025/2026 again
Published on 05/27/2026 at 16:10, 1 hour ago Michter's Announces 2026 Release of Its Coveted 10 Year Rye
Published on 05/27/2026 at 11:51, 5 hours 19 minutes ago Statement of transactions in own shares from May 18, 2026 to May 22, 2026
Published on 05/26/2026 at 18:39, 22 hours 31 minutes ago Reporting on share buyback transactions carried out on May 18, 2026
Published on 05/26/2026 at 17:45, 23 hours 26 minutes ago EURAZEO INVESTS IN BABYLON, A FRENCH OPERATOR OF NEXT-GENERATION APARTHOTELS
